𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The Longitudinal Course of Cardiomyopathy in Friedreich’s Ataxia During Childhood

✍ Scribed by Alaina Kipps; Mark Alexander; Steven D. Colan; Kimberlee Gauvreau; Leslie Smoot; Lisa Crawford; Basil T. Darras; Elizabeth D. Blume

Publisher
Springer
Year
2008
Tongue
English
Weight
183 KB
Volume
30
Category
Article
ISSN
0172-0643

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of the factors influencing the
Analysis of the factors influencing the cardiac phenotype in Friedreich's ataxia
✍ Bheeshma Rajagopalan; Jane M. Francis; Fraser Cooke; L. V. Prasad Korlipara; And 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Friedreich's ataxia (FRDA) has been associated with both cardiac hypertrophy and to a lesser degree dilated cardiomyopathy. We have conducted a cross sectional magnetic resonance imaging (MRI) study of 25 patients with clinically and genetically confirmed FRDA and 24 healthy controls to analyse how

Intrathecal baclofen in the treatment of
Intrathecal baclofen in the treatment of painful, disabling spasms in Friedreich's ataxia
✍ Djamel Ben Smail; Claire Jacq; Pierre Denys; Bernard Bussel 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

## Abstract We report on the case of a patient suffering from Friedreich's ataxia (FA) with very painful and disabling spasms that were improved markedly by intrathecal baclofen infusion. To our knowledge, this is the first report of an intrathecal baclofen‐delivering pump implantation in an FA pat

Could thiazolidinediones increase the ri
Could thiazolidinediones increase the risk of heart failure in Friedreich's ataxia patients?
✍ José L. García-Giménez; Fabián Sanchis-Gomar; Federico V. Pallardó 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

Clinical evidence and the recent decisions of the European Medicines Agency and the Food and Drug Administration challenge the safety of thiazolidinediones treatment. Recently, this treatment has been suggested for Friedreich's ataxia because thiazolidinediones improve neurological symptoms. Hypertr